Creation of the World's First "Neuromap" by Utah-based Recursion Pharmaceuticals Triggers a $30 Million Payment from Roche and Genentech
Recursion breakthrough leads to new type of mapping the brain.
Providing perspective and contextual insights on the monetary aspects of the Healthcare market within the state of Utah, from medical providers to insurance and from nutraceuticals to medical devices.